NDC11 65219036802
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 65219-0368-02 | 65219-0368 |
| 65219-0368-2 | 65219-0368 |
| 65219-368-02 | 65219-368 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lorazepam | LORAZEPAM | Fresenius Kabi USA, LLC | 462a13da-259a-40e7-bd5b-f7f42ae025b7 | 2026-03-13 | Boxed warning, Warnings, Adverse reactions | 65219-368 |
| Lorazepam | LORAZEPAM | Fresenius Kabi USA, LLC | b2487467-a63f-48b5-b0de-3a6ce6672d50 | 2024-11-26 | Boxed warning, Warnings, Adverse reactions | 65219-368-02 65219-368 65219036802 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.